"Would anyone like to hear of a new big time CEO h
Post# of 158772
That would be a not so smart move. You do not disrupt a reputable CEO of a small biomedical company and his relationship with the FDA that has been turned around 180 degrees from a few years ago due to hard work, a good plan and a real belief in the drug.
JL has done the groundwork and started the most direct paths forward to obtain approval for leronlimab.
Once CYDY has an approval then perhaps a CEO skilled in business might be considered but until the approval, we have a clinician/researcher CEO with a very strong supporting cast making the correct moves to obtain approval from the FDA.
The several year delay engendered by the previous clown show management is in the rear view mirror. I know it sounds trite but...... patience while the studies progress!